Clinical resource
Respiratory non-small cell lung cancer definitive EBRT with or without chemotherapy (eviQ ID 1871)
eviQ, Cancer Institute NSW
DoseLab summary
Endorsed eviQ protocol for definitive conventionally fractionated NSCLC treatment. DoseLab's conventional lung constraint table reproduces its organs-at-risk values and citations. Check the live page for the current version.
Why this is useful
Constraints for conventionally fractionated definitive lung treatment, drawn mainly from QUANTEC and dose–toxicity studies, with the risk each constraint targets.
Reference details
- Title
- Respiratory non-small cell lung cancer definitive EBRT with or without chemotherapy (eviQ ID 1871)
- Authors / organization
- eviQ, Cancer Institute NSW
- Publication / protocol
- eviQ Radiation Oncology protocol 1871
- Version
- v.7 — last reviewed 16 March 2023; review due 30 June 2027
- Year
- 2023
- DOI
- Pending verification
- Disease sites
- Lung
- Topics
- Conventional fractionation, Dose Constraints, Chemoradiation, Protocols
- Fractionation context
- 60 Gy in 30 fractions
- Last reviewed by DoseLab
- 2026-09-22